Clinical Trials Logo

Macular Holes clinical trials

View clinical trials related to Macular Holes.

Filter by:

NCT ID: NCT03701542 Completed - Macular Holes Clinical Trials

The Application of M-charts and Microperimetry for the Assessment of Visual Function in Patients After Vitrectomy Due to the Full Thickness Macular Hole.

Start date: January 1, 2016
Phase:
Study type: Observational

To examine the relationship between morphological and functional results in eyes after vitrectomy due to the full thickness macular hole (FTMH).

NCT ID: NCT03646695 Completed - Macular Holes Clinical Trials

ILM Flap Transposition Versus ILM Peeling for Macular Holes: a Pilot Study

Start date: September 1, 2018
Phase: N/A
Study type: Interventional

Patients with macular hole <400µm will be randomized for ILM flap Transposition and ILM Peeling for surgical repair of macular holes

NCT ID: NCT03572725 Completed - Macular Holes Clinical Trials

Air Tamponade and Non-supine Positioning in Macular Hole Surgery.

Start date: September 26, 2018
Phase: N/A
Study type: Interventional

This is a prospective, multicenter, randomized non-inferiority trial, where the macular hole closure rate with intraocular air tamponade is compared to the closure rate with gas tamponade.The patients are randomized to receive either air or gas (26% SF6) as intraocular tamponade, just prior to the intraocular flushing of the tamponade during the vitrectomy procedure. Postoperatively, the patients adhere to the nonsupine regimen for three days, and the tennis ball technique is used during sleep to enhance patients' positioning compliance.

NCT ID: NCT03525899 Completed - Clinical trials for Proliferative Diabetic Retinopathy

Macular Hole After Diabetic Vitrectomy

Start date: November 1, 2017
Phase:
Study type: Observational

To present the clinical characteristics and rational treatment of macular hole (MH) after the diabetic vitrectomy (DV) in patients with proliferative diabetic retinopathy (PDR).

NCT ID: NCT03437759 Active, not recruiting - Macular Holes Clinical Trials

MSC-Exos Promote Healing of MHs

MSCs
Start date: March 1, 2017
Phase: Early Phase 1
Study type: Interventional

Purpose: To assess the safety and efficacy of mesenchymal stem cells (MSCs) and MSC-derived exosomes (MSC-Exos) for promoting healing of large and refractory macular holes (MHs). Hypothesis: MSC and MSC-Exo therapy may promote functional and anatomic recovery from MH. MSC-Exo therapy may be a useful and safe method for improving visual outcomes of surgery for refractory MHs.

NCT ID: NCT03433547 Completed - Macular Holes Clinical Trials

Effects of Macular Buckle Versus Vitrectomy on Macular Hole and Macular Detachment in Highly Myopic Eyes

Start date: January 30, 2018
Phase: N/A
Study type: Interventional

Full-thickness macular Hole associated with macular detachment is a one of the maculopathies of high myopia. There is controversy in the primary treatment for this situation. This study will compare the effects of macular buckling versus vitrectomy in a cohort of highly myopic eyes with this situation.

NCT ID: NCT03383731 Recruiting - Retinal Detachment Clinical Trials

A Study of a New Surgical Treatment of Macular Hole Retinal Detachment in High Myopia

Start date: April 7, 2017
Phase: N/A
Study type: Interventional

This study evaluates the surgical outcomes of inverted internal limiting membrane insertion combined with air tamponade in the treatment of macular hole retinal detachment (MHRD) in high myopia, and also to compare the treatment efficacy and safety between different surgical approaches of MHRD

NCT ID: NCT03174639 Completed - Retinal Detachment Clinical Trials

High Myopia Macular Hole and Retinal Detachment Treated With Double ILM Flaps

Start date: March 11, 2016
Phase: N/A
Study type: Interventional

From July 2015 to December 2015, clinical record of 8 consecutive cases of macular hole with retinal detachment in high myopia treated with combined inverted and free ILM flap insertion into the hole were retrospectively reviewed. The anatomical and function outcomes were assessed.

NCT ID: NCT02203929 Completed - Macular Holes Clinical Trials

Preoperative Progression of Macular Holes

Start date: June 2014
Phase: N/A
Study type: Observational

Knowledge of the natural history and progression of macular holes is mainly limited to the studies from the pre-optical coherence tomography era. By observing macular holes preoperatively we are able to determine the extent of the preoperative macular hole progression. At our institution macular holes are treated in an elective setting. The majority of macular holes undergo a 2-step sequence of phacoemulsification and intraocular lens implantation followed by vitrectomy. We wish to observe the effect of time and cataract surgery on the progression of macular holes prior to vitrectomy.

NCT ID: NCT02073266 Completed - Cataract Clinical Trials

Impact of C3F8 or SF6 Use and Length of Face-down Positioning (7 vs 14 Days Respectively) in Macular Hole Surgery

Start date: January 2010
Phase: N/A
Study type: Interventional

The primary purpose of the study was to compare the macular hole closure and visual acuity gain following vitrectomy using SF6 gas tamponade with 7 days of face-down positioning versus C3F8 gas tamponade with 14 days of face-down positioning. The secondary purpose was to report, in each group, the cumulative incidence of cataract development 1 year following macular hole surgery and the proportion of complications (*). ((*) hypertony, hypotony, retinal tear, retinal detachment and endophthalmitis) This prospective randomized study examined a 3 year period. The first patient was included in January 2010 and the last in November 2011. The 12-month follow-up spread out from March 2011 to December 2012. The first group included 31 patients who had undergone macular hole surgery using SF6 gas and who were advised to stay in face-down position for 7 days postoperatively (SF6 group). These patients were compared to 28 patients who had undergone macular hole surgery with C3F8 gas and who were advised to maintain a face-down position for 14 days. Patients in both groups underwent vitrectomy, internal limiting membrane peeling, and fluid-gas exchange using either SF6 or C3F8. Preoperative data included the characterization of the hole with Optical Coherence Tomography (OCT), the best correct visual acuity (VA) recorded in number of letters using the Early Treatment Diabetic Retinopathy Study (ETDRS) chart, classification of the cataract according to the LOCS III and the intraocular pressure IOP. Postoperative data included OCT confirmation of the closure at 6 weeks and 1 year, 1 year's best corrected VA recorded in number of letters (EDTRS chart) and determination of cataract development and extraction as needed.